S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

Innovator IBD 50 ETF Stock Forecast, Price & News

-0.18 (-0.37 %)
(As of 10/15/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume102,330 shs
Average Volume87,694 shs
Market Capitalization$252.10 million
P/E RatioN/A
Dividend Yield0.00%
30 days | 90 days | 365 days | Advanced Chart
Receive FFTY News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovator IBD 50 ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Innovator Capital Management
Fund NameInnovator IBD 50 ETF
Tax ClassificationRegulated Investment Company
Inception Date4/8/2015
Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai

Fund Focus

Asset ClassEquity
BenchmarkIBD 50 Index
CategoryBroad Equity
FocusBroad Equity
Development LevelBlended Development

Fund Statistics

Assets Under Management$252.93 million
Average Daily Volume$120,226.50

ETF Expenses

Management Fee0.70%
Other Expenses0.33%
Total Expenses1.03%
Fee Waiver-0.23%
Net Expenses0.80%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorInnovator Capital Management, LLC
CustodianU.S. Bank, N.A.
DistributorForeside Fund Services, LLC
Transfer AgentU.S. Bank, N.A.
Lead Market MakerVirtu Financial

Geographic Exposure of FFTY

Currency Exposure of FFTY

Sector Exposure of FFTY

Industry Exposure of FFTY

Innovator IBD 50 ETF (NYSEARCA:FFTY) Frequently Asked Questions

What stocks does MarketBeat like better than Innovator IBD 50 ETF?

Wall Street analysts have given Innovator IBD 50 ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Innovator IBD 50 ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Innovator IBD 50 ETF's stock been impacted by COVID-19?

Innovator IBD 50 ETF's stock was trading at $29.60 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, FFTY stock has increased by 63.8% and is now trading at $48.48.
View which stocks have been most impacted by COVID-19

What other stocks do shareholders of Innovator IBD 50 ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innovator IBD 50 ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Bank of America (BAC), AbbVie (ABBV), Advanced Micro Devices (AMD), Arista Networks (ANET), Activision Blizzard (ATVI), Micron Technology (MU), Adobe (ADBE) and Applied Materials (AMAT).

What is Innovator IBD 50 ETF's stock symbol?

Innovator IBD 50 ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FFTY."

Who are Innovator IBD 50 ETF's major shareholders?

Innovator IBD 50 ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Wedbush Securities Inc. (0.28%), First Hawaiian Bank (0.12%) and Financial Enhancement Group LLC (0.05%).

Which institutional investors are buying Innovator IBD 50 ETF stock?

FFTY stock was purchased by a variety of institutional investors in the last quarter, including First Hawaiian Bank, Financial Enhancement Group LLC, and Wedbush Securities Inc..

How do I buy shares of Innovator IBD 50 ETF?

Shares of FFTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Innovator IBD 50 ETF's stock price today?

One share of FFTY stock can currently be purchased for approximately $48.48.

How much money does Innovator IBD 50 ETF make?

Innovator IBD 50 ETF has a market capitalization of $252.10 million.

This page was last updated on 10/17/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.